Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus

Gene Therapy

Volumn 5, Issue 2, 1998, Pages 277-281

  Lalwani, A K ^a,c   Walsh, B J ^a   Reilly, P G ^a   Carvalho, G J ^a   Zolotukhin, S ^b   Muzyczka, N ^b   Mhatre, A N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Laboratory of Molecular Otology   (United States)

Author keywords

Adeno associated virus; Cochlea; Hearing disorders; galactosidase

Indexed keywords

BETA GALACTOSIDASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; COCHLEA; CONTROLLED STUDY; CORTI ORGAN; CYTOARCHITECTURE; GENE EXPRESSION; GENE TRANSFER; GUINEA PIG; HEARING DISORDER; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SPIRAL GANGLION; TRANSGENE; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); CAVIA PORCELLUS; SUS SCROFA;

EID: 0031885546     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300573     Document Type: Article

References (14)

1. Geschwind MD et al. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum Gene Ther 1996; 7: 173-182.
2. Raphael Y, Frisancho JC, Roessler BJ. Adenovirus-mediated gene transfer into guinea pig cochlear cells in vivo Neurosci Lett 1996; 207: 137-141.
3. Lalwani AK et al. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Therapy 1996; 3: 588-592.
4. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992; 158: 97-129.
5. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993; 90: 10613-10617.
6. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
7. Flotte TR, Afione SA, Zeitlin PL. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 1994; 11: 517-521.
8. Samulski RJ et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 (published erratum appears in EMBO J 1992; 11: 1228). EMBO J 1991; 10: 3941-3950.
9. Scharfmann R, Axelrod JH, Verma IM. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci USA 1991; 88: 4626-4630.
10. Kaplitt MG et al. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc Natl Acad Sci USA 1994; 91: 8979-8983
11. Halbert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995; 69; 1473-1479
12. Zolotukhin S et al. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
13. Lalwani AK et al. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res (in press).
14. Kelsell DP et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997; 387, 80-83